Ultrasound findings can improve classification of RA

Ultrasound findings can improve classification of RA
Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League Against Rheumatism criteria for identifying patients with a disease requiring methotrexate treatment, according to research published in the April issue of Arthritis & Rheumatism.

(HealthDay)—Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria for identifying patients with a disease requiring methotrexate (MTX) treatment, according to research published in the April issue of Arthritis & Rheumatism.

Daiki Nakagomi, M.D., of the Chiba University Hospital in Japan, and colleagues analyzed data from 193 patients with musculoskeletal symptoms for at least three years to determine if the accuracy of the 2010 ACR/EULAR in classifying rheumatoid arthritis can be improved using different definitions of synovitis detected by ultrasonography.

According to the researchers, for clinical synovitis
(tenderness or swelling), the sensitivity and specificity of the 2010 ACR/EULAR criteria using different definitions of synovitis to identify patients who developed a disease requiring MTX were 58.5 and 79.4 percent, respectively. The sensitivity and specificity for -detected synovitis with a gray-scale (GS) imaging score ≥1 were 78.0 and 79.4 percent, respectively; the sensitivity and specificity for GS ≥2 ultrasound synovitis or a synovial power Doppler signal score ≥1 were 56.1 and 93.7 percent, respectively.

"We demonstrated that criteria based on ultrasound findings may classify more accurately patients who subsequently require MTX treatment than do criteria not based on ultrasound findings," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Ultrasound model IDs residual joint inflammation in RA

date Apr 18, 2013

(HealthDay)—A model including ultrasound (US) assessment of the wrist, metacarpophalangeal (MCP), ankle, and metatarsophalangeal (MTP) joints is highly sensitive for detecting B-mode and Doppler joint inflammation ...

Myogenes identified for spondyloarthritis synovitis

date Sep 27, 2012

(HealthDay)—There are disease-specific and inflammation-independent stromal alterations in spondyloarthritis (SpA) synovitis, according to a study published online Sept. 12 in Arthritis & Rheumatism.

Recommended for you

New test could predict arthritis drug failure in patients

date 3 hours ago

A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings ...

About 8 percent of SLE patients have pulmonary HTN

date Jun 23, 2015

(HealthDay)—About 8 percent of patients with systemic lupus erythematosus (SLE) have pulmonary hypertension (PH), and serum uric acid (UA) has reasonable accuracy for predicting PH, according to a study ...

Early age of menopause linked to seropositivity in RA

date Jun 17, 2015

(HealthDay)—In women with early rheumatoid arthritis (RA), early age at menopause is associated with seropositivity, according to a study published in the May issue of Arthritis Care & Research.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.